Company Name:Exelixis Inc.
CEO: Michael M. Morrissey

Sector: Healthcare
Industry:Biotechnology

Exchange: Nasdaq Global Select

Country: USA

Description: Exelixis Inc is a biotechnology company. It is involved in discovery, development, and commercialization of new medicines for people with cancer. The Cabometyx product generates maximum revenue for the company.


Key numbers

Market Capitalization:6022227720
Shares Outstanding: 303846000
Float: 293727928
Next Earning Date:2020-03-03
TTm EPS: 2.0377
TTm Dividend Rate:
200 days moving average:19.26
50 days moving average: 17.49
One day percent Change: -3.03



2018-06-30, 2018-09-30, 2018-12-31, 2019-03-31,
2018-06-30, 2018-09-30, 2018-12-31, 2019-03-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,